Rekord LOINC: 95184-8

This panel contains results for Cytomegalovirus (CMV) CD8 T-Cell immune competence by Flow Cytometry. Patients tested are cytomegalovirus (CMV)-seropositive and may have 1 or more of the 5 major histocompatibility complex (MHC) alleles, including HLA A1, A2, B7, B8, or B35. Testing is performed to monitor CMV-specific CD8 T-cell responses in patients at higher risk of CMV disease. Testing may be performed on allo-hematopoietic stem cell or solid organ transplant patients who are at risk for developing late CMV disease or having CMV reactivation post transplant or after the cessation of antiviral prophylaxis. For transplant recipients and patients with autoimmune disorders receiving therapy with immunosuppressant agents, testing is useful for determining over immunosuppression within the CD8 T cell pathway. This panel was created for, but not limited in use to, Mayo's CMV CD8 T-Cell Immune Competence Quantitative Assessment by Flow Cytometry.[https://www.mayocliniclabs.com/test-catalog/Overview/88826]

Cytomegalowirus Niedobór odporności komórek T na CMV, panel